Press/Media
Six Questions Benefit Providers Should Ask Their PGx Partner
Nov 24, 2021
Click here to read "Six Questions Benefit Providers Should Ask Their PGx Partner"
Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians
Nov 09, 2021
Click here to read the article on the GlobeNewswire website
Inagene Diagnostics Inc. and Granville Biomedical Inc. team up to provide locally-produced pharmacogenetic testing kits to Canadians
Nov 09, 2021
Click here to read the article on the GlobeNewswire website
Pharmacogenetic testing uses DNA to predict patients’ responses to medications
Nov 09, 2021
Click here to read the article on the Globe and Mail website
September's International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain…
Nov 09, 2021
Click here to read the article on the Financial Post website
Canada's surgery backlog could lead to wave of new chronic pain and opioid dependencies According to Inagene Diagnostics Inc., genetic testing can help mitigate the risk of chronic pain and reliance on medications
Nov 09, 2021
Click here to read the article on the Financial Post website
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing…
Nov 09, 2021
Click here to read the article on the Financial Post website
Inagene Pharmacogenetic Testing Featured on Global News
Nov 08, 2021
Click here to watch the Global News segment featuring Inagene Pharmacogenetic Testing